Business News • PR NewsWire • Dragonfly Biosciences UK Expects to Commence Trading under the Symbol DRF on the Australian Securities Exchange Ltd (ASX) early January 2022

Dragonfly Biosciences UK Expects to Commence Trading under the Symbol DRF on the Australian Securities Exchange Ltd (ASX) early January 2022

Dragonfly Biosciences UK Expects to Commence Trading under the Symbol DRF on the Australian Securities Exchange Ltd (ASX) early January 2022

Prospectus Approved by the Australian Securities and Investments Commission LONDON, Dec. 10, 2021 /PRNewswire/ -- British Company, Dragonfly Biosciences UK, the makers of Dragonfly CBD, Europe's largest and leading, award winning seed to shelf range of CBD oils and skincare products, is...

View More : https://www.prnewswire.com:443/news-releases/dragonfly-biosciences-uk-expects-to-commence-trading-under-the-symbol-drf-o...

Releted News by prnewswire

Klarna launches browser extension allowing consumers to pay later across all online stores

Il nuovo sondaggio di Medtech rivela l'urgenza di armonizzare i processi normativi e di ottimizzare la presentazione della documentazione

Concentric AB changes the date for Interim Report for the full year 2021 and invites to a conference call

Dragonfly Biosciences UK Expects to Commence Trading under the Symbol DRF on the Australian Securities Exchange Ltd (ASX) early January 2022

Laboratory Consumables Primary Packaging Market size to grow by USD 1.28 Bn | Dominated by Becton Dickinson and Co., Bellco Glass Inc., and CoorsTek Inc. | 17,000+ Technavio Research Reports

Newgen Secures Patent for Integrated Capture and Analysis of Documents

Johnson Fistel, LLP Announces That It Has Filed a Class Action Lawsuit on Behalf of Cloopen Group Holding Limited Investors Alleging Violations of the Federal Securities Laws